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Background: Activation of metabotropic glutamate receptor 5 (mGluR5) by (RS)-2-chloro-5-hydroxyphenylglycine
(CHPG) was shown to suppress microglia activation and decrease the release of associated pro-inflammatory
mediators. In contrast, the consequences of mGluR5 inhibition are less well understood. Here, we used BV-2 cells,
retaining key characteristics of primary mouse microglia, to examine whether mGluR5 inhibition by 2-methyl-6-
(phenylethynyl)-pyridine (MPEP) enhances cellular stress and production of inflammatory mediators.
Methods: BV-2 cells were treated with MPEP, followed by determination of cellular stress using fluorescent dyes and
high-content imaging. The expression of inflammatory mediators, endoplasmic reticulum (ER)-stress markers and
phosphorylated AMPKα was analyzed by quantitative PCR, ELISA and Western blotting. Additionally, phospholipase C
(PLC) activity, cellular ATP content and changes in intracellular free Ca2+ ([Ca2+]i) were measured using luminescence
and fluorescence assays.
Results: Treatment of BV-2 microglia with 100 μM MPEP increased intracellular reactive oxygen species (ROS),
mitochondrial superoxide, mitochondrial mass as well as inducible nitric oxide synthase (iNOS) and IL-6 expression.
Furthermore, MPEP reduced cellular ATP and induced AMPKα phosphorylation and the expression of the ER-stress
markers CHOP, GRP78 and GRP96. The MPEP-dependent effects were preceded by a rapid concentration-dependent
elevation of [Ca2+]i, following Ca
2+ release from the ER, mainly via inositol triphosphate-induced receptors (IP3R). The
MPEP-induced ER-stress could be blocked by pretreatment with the chemical chaperone 4-phenylbutyrate and the
Ca2+ chelator BAPTA-AM. Pretreatment with the AMPK agonist AICAR partially abolished, whilst the inhibitor compound
C potentiated, the MPEP-dependent ER-stress. Importantly, the PLC inhibitor U-73122 and the Gi-protein inhibitor
pertussis toxin (PTX) blocked the MPEP-induced increase in [Ca2+]i. Moreover, pretreatment of microglia with AICAR,
BAPTA-AM, U-73122 and PTX prevented the MPEP-induced generation of oxidative stress and inflammatory mediators,
further supporting a role for Gi-protein-mediated activation of PLC.
Conclusions: The results emphasize the potential pathophysiological role of mGluR5 antagonism in mediating
oxidative stress, ER-stress and inflammation through a Ca2+-dependent pathway in microglia. The induction of cellular
stress and inflammatory mediators involves PTX-sensitive Gi-proteins and subsequent activation of PLC, IP3R and Ca
2+
release from the ER.
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Neuroinflammation involves the activation and recruit-
ment of immune cells, including microglia, macrophages
and lymphocytes, as well as an expression of factors de-
signed to respond to injury and aid in repair. Microglia
are resident immune cells in the central nervous system
and play an integral role in the neuroinflammatory re-
sponse. However, excessive microglial activation is a
hallmark of neurodegenerative diseases [1].
Metabotropic glutamate receptors (mGluRs) are expressed
in many different cell types throughout the brain and
spinal cord [2]. They have been considered as promising
targets for neuro-protective agents in acute and chronic
neurodegenerative disorders [3,4]. The mGluRs are G-
protein-coupled receptors (GPCRs) consisting of eight
subtypes divided into three groups (I to III) based on their
sequence homology, signal transduction pathways and
pharmacological profiles [3,5]. The mGluR5 belongs to
the group I members, which are typically postsynaptic in
neurons and mediate their signaling through Gαq-
proteins. Activation results in the stimulation of phospho-
lipase C (PLC) and phosphoinositide hydrolysis, leading to
intracellular Ca2+ mobilization and activation of extra-
cellular signal-regulated kinases 1 and 2 (ERK1/2) down-
stream signaling pathways [3]. High expression of mGluR5
was found in activated microglia [2,6], which surround the
site of injury following traumatic brain injury in rats, sug-
gesting pharmacological mGluR5 manipulation may be
beneficial in neuroinflammatory diseases [7,8]. Indeed, the
specific mGluR5 agonist (RS)-2-chloro-5-hydroxyphenyl-
glycine (CHPG) was shown to inhibit microglial activation,
oxidative stress and the release of inflammatory mediators
both in vitro and in vivo [9-14]. Furthermore, the use of
agonists to treat chronic spinal cord injuries has been pro-
posed [4]. Thus, a dysregulation resulting in decreased
mGluR5 activity may promote the initiation and/or pro-
gression of neurodegenerative disorders.
An excessive activation of microglia leads to the en-
hanced production of ROS and reactive nitrogen species
(RNS), which promotes pro-inflammatory pathways via the
activation of mitogen-activated protein kinases (MAPKs)
and nuclear factor kappa-light-chain-enhancer of activated
B cells (NF-κB) [15-18]. The mGluR5 affects ROS and ni-
tric oxide (NO) production through inhibition of NADPH
oxidase (NOX-2) activity [9,12-14]; however, the underlying
mechanisms are not fully understood. The brain has a high
energy demand and therefore depends on efficient mito-
chondrial function. Impaired mitochondrial dynamics and
the chronic generation of ROS and RNS contribute to the
pathogenesis of several neurodegenerative diseases [19,20].
A key regulator of mitochondrial adenosine triphosphate
(ATP) production is AMP-dependent protein kinase
(AMPK), which positively regulates signaling pathways
replenishing ATP [21]. Although AMPK is consideredto be a pro-survival kinase, its prolonged activation can in-
duce endoplasmic reticulum (ER)-stress, thereby causing
cell damage [22-25]. AMPK is directly targeted and acti-
vated by pro-oxidant species and by elevated intracellular
Ca2+ levels ([Ca2+]i) [23,26], which can result in enhanced
MAPK signaling and apoptosis.
Changes in [Ca2+]i have been implicated in the regulation
of several activities of microglia, including proliferation,
migration, cytokine release and ROS generation [27-30].
Different stimuli can lead to increased [Ca2+]i, either by
Ca2+ release from the ER or by entry through the plasma
membrane [31]. The ER Ca2+ store is regulated by two
Ca2+ release channels, the inositol triphosphate-induced
receptor (IP3R) [32,33] and the ryanodine receptor (RyR)
[33], as well as by Ca2+ ATPases, which control Ca2+ re-
uptake into the ER [33]. Both, a prolonged Ca2+ depletion
in the ER and a Ca2+ overload in the cytoplasm can cause
ER-stress [34]. Activation of the unfolded protein response
(UPR), consisting of the up-regulation of ER-chaperones,
attenuation of protein translation and ER-associated deg-
radation of misfolded proteins [35], counteracts ER-stress.
The ER-resident molecular chaperones glucose-regulated
protein 78 (GRP78) and glucose-regulated protein 94
(GRP94) as well as the transcription factor C/EBP homolo-
gous protein (CHOP) are induced by the UPR and they in-
crease ER protein-folding capacity and maintain ER Ca2+
stores [35]. Prolonged ER-stress ultimately results in cell
death by the apoptotic pathway mediated by caspase-12,
an ER localized cysteine protease [35]. In addition to Ca2+
homeostasis, impaired mitochondrial function and AMPK
signaling modulate the ER-stress response [36-38].
GPCRs play an important role in controlling microglial
cell activity. The activation of mGluR5 in microglia has
been suggested to involve the Gαq-protein signal trans-
duction pathway through PLC, PKC and Ca2+ [10]. Upon
stimulation of GPCRs, the inactive Gα-GDP/Gβγ hetero-
trimers release GDP and bind GTP, resulting in the dis-
sociation of Gα from Gβγ. The resulting GTP-Gαq
complex activates the β-isoforms of PLC [39]. However, a
role for pertussis toxin (PTX)-sensitive Gi proteins in IP3
signaling and [Ca2+]i increase has not, to our knowledge,
been reported in microglia.
In order to elucidate the effects of the pharmacological
inhibition of mGluR5 on cellular stress and inflammatory
mediators in microglia, we tested the responsiveness of
BV-2 mouse microglia to the selective mGluR5 antagonist
MPEP. There is a close resemblance between BV2 cells
and primary mouse microglia in terms of their inflamma-
tory signaling pathways; therefore, BV-2 microglial cells
can be used as a model for the activation of microglia
in vitro [40,41]. In the present study, we show that BV-2
microglia represent a suitable cell model for studying the
signaling pathway downstream of mGluR5. Our results
provide evidence for a PLC- and IP3R-dependent increase
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Importantly, the mGluR5-dependent effects could be
blocked by PTX, indicating the involvement of a Gi
protein-dependent signal transduction pathway.
Experimental procedures
Materials
DMEM, RPMI-1640 medium, penicillin, streptomycin,
0.05% (w/v) trypsin/EDTA, non-essential amino acids
(NEAA), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES), Hank’s balanced salt solution (HBSS), EnzChek
Direct PLC assay kit, Hoechst-33342, dihydroethidium
(DHE), Mitotracker Red CMXRos, MitoSOX Red, Fluo-
4 AM and probenecid were obtained from Invitrogen
(Carlsbad, CA, USA). FBS was obtained from Connectorate
(Dietikon, Switzerland), Cell Titer Glo® assay kit from
Promega (Madison, WI, USA) and thapsigargin, AICAR,
(RS)-2-chloro-5-hydroxyphenylglycine (CHPG), 6-methyl-
2-(phenylethynyl)-pyridine (MPEP), BAPTA-AM, pertussis
toxin (PTX), dantrolene sodium and sodium phenylbuty-
rate (PBA) from Sigma-Aldrich (St. Louis, MO, USA).
Compound C and xestospongin C were obtained from
Calbiochem (San Diego, CA, USA). Specific antibodies
against GRP78, AMPK, and its phosphorylated form were
obtained from Cell Signaling Technology (Danvers, MA,
USA). Specific antibodies against β-actin and goat anti-
rabbit IgG-horseradish peroxidase were obtained from
Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Cell culture and experimental procedure
Murine BV-2 microglia, immortalized by infection with
v-raf/c-myc recombinant retrovirus [42], were kindly pro-
vided by Professor Wolfgang Sattler, University of Graz,
Austria. BV-2 cells were propagated in 75 cm2 flasks in
RPMI-1640 medium supplemented with 10% FBS, 2 mM
glutamine, 100 μg/mL streptomycin and 100 U/mL peni-
cillin, 10 mM HEPES and 0.1 mM NEAA at 37°C, 5%
CO2. Prior to initiating the experiments, cells were resus-
pended in DMEM supplemented with 10% FBS, 1 g/L glu-
cose, 2 mM glutamine, 100 μg/mL streptomycin and 100
U/mL penicillin, 10 mM HEPES and 0.1 mM NEAA, and
seeded again to reach 70% confluence. Cells were then dis-
tributed to 96-well (1 × 103 cells/well), 24-well (2 × 104
cells/well), 12-well (5 × 105 cells/well) or 6-well (1.0 × 106
cells/well) plates. Cells in the exponential growth phase
(60 to 70% confluence) were used for the experiments.
Determination of mRNA expression
Tri-reagent was used to isolate total RNA according to the
manufacturer’s instructions (Sigma-Aldrich, St. Louis, MO,
USA). Complementary DNA (cDNA) was synthesized
from 0.5 μg total RNA using Superscript III reverse tran-
scriptase (Invitrogen, Carlsbad, CA, USA). Briefly, in the
first step 0.5 μg of sample RNA and 0.5 μg oligo (dT)15were made up to a final volume of 12 μL in DNase/RNase-
free water in 0.5 mL tubes, which were incubated at 65°C
for 5 minutes and immediately transferred to ice. Secondly,
reverse transcription reaction mixture (8 μL), containing
4 μL of 5 × first strand buffer (Invitrogen, Carlsbad, CA,
USA), 2 μL 0.1 M DTT, 10 U Protector of RNase Inhibitor
(Roche Diagnostics, Mannheim, Germany), 0.5 mM dNTP
and 20 U Superscript III reverse transcriptase, was added
to each sample. Samples were incubated at 42°C for 1 hour.
Samples were diluted in DNase/RNase-free water to a
working stock of 5 ng/μL of cDNA. Relative mRNA quan-
tification was performed by real-time RT-PCR using a
rotor-gene 6000 (Corbett Research, Sydney, Australia).
Briefly, the reverse transcriptase was mixed with the
cDNA (10 ng), gene-specific primers (200 nM) (Additional
file 1: Table S1) and KAPA SYBR FAST qPCR reagent
(Kapasystems, Boston, MA, USA) (5 μL), in a final volume
of 10 μL. Thermal cycler parameters were as follows:
15 minutes at 95°C, followed by amplification of cDNA
for 40 cycles with melting for 15 seconds at 94°C, anneal-
ing for 30 seconds at 56°C and extension for 30 seconds at
72°C. For each sample, three replicates were analyzed.
Expression was normalized to GAPDH control. Fold
changes were quantified as 2-(ΔCt sample-ΔCt control), as de-
scribed previously [43].
Analysis of protein expression
Cells grown in 6-well plates and treated with selected
compounds were washed twice with ice-cold PBS and har-
vested in cold RIPA buffer (Sigma-Aldrich, St. Louis, MO,
USA) supplemented with 2% protease inhibitor cocktail
(Roche Diagnostics, Mannheim, Germany). Extracts were
centrifuged at 10,000 × g for 15 minutes at 4°C in order to
remove cell debris.
Protein concentrations were determined using the Pierce®
BCA protein assay kit (Thermo Scientific, Waltham, MA,
USA) using BSA as protein standard. Absorbance was mea-
sured at 595 nm using a UV-max kinetic microplate reader
(Molecular Devices, Devon, UK).
Equal amounts of cellular proteins (30 μg/sample) were
separated by 10% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and transferred onto
polyvinylidene difluoride (PVDF) membranes (Bio-Rad
Laboratories, Hercules, CA, USA) at 120 mA for 1 hour.
The membranes were blocked for 1 hour in Tris-buffered
saline (TBS), pH 7.4, with 0.1% Tween-20 (TBS-T) con-
taining 10% non-fat milk. The blots were then incubated
overnight at 4°C with primary antibodies against AMPKα
(D63G4) (1:1,000), phospho-AMPKα (Thr172) (1:1,000),
GRP78 (1:500) and β-actin (1:2,000) in TBS-T containing
5% non-fat milk. The membranes were washed 4 × 15 mi-
nutes with TBS-T and incubated with goat anti-rabbit
IgG-horseradish peroxidase (1:5,000) for 2 hours. After
washing the membranes with TBS-T, immunolabeling was
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strate (Millipore, Billerica, MA, USA) using a Fujifilm LAS-
4000 detection system (Bucher Biotec, Basel, Switzerland).
β-actin served as loading control of whole cell protein
extracts.
Measurement of intracellular ROS, mitochondrial mass
and mitochondrial superoxide by ArrayScan® high-
content imaging
Cellular ROS, mitochondrial mass and mitochondrial
superoxide were detected using the specific fluorescent
dyes dihydroethidium (DHE), MitoTracker®Red CMXRos
and MitoSOX Red (Invitrogen, Carlsbad, CA, USA). After
the treatments, DHE (10 μg/mL), MitoTracker®Red
CMXRos (200 nM) or MitoSOX Red (5 μM) were added
to living cells, followed by incubation for 10, 30 and 20 mi-
nutes, respectively. Cells were washed twice with PBS,
fixed with 4% formaldehyde for 15 minutes and perme-
abilized by washing twice with 0.1% Triton X-100 in PBS.
Nuclei were stained for 30 minutes with 1 μg/mL
Hoechst-33342 dissolved in medium. Stained cells were vi-
sualized, images captured and the amount of fluorescence
was quantified using an ArrayScan® high-content imaging
system (Cellomics Inc, Pittsburgh, PA, USA). Fluorescence
intensities of each dye were quantified with the cell health
profiling bioapplication module. Objects were captured
with the appropriate filter on 20 fields, with a total count
of approximately 1,000 cells. Cells were identified using
Hoechst-33342 dye and a nuclear mask was generated
from images of Hoechst-stained nuclei. The values for
intracellular ROS, mitochondrial mass and mitochondrial
superoxide were expressed as percentage of fluorescence
intensity compared with values of the control group.
PLC activity assay
Phosphatidylcholine-specific PLC activity was determined
in whole-cell lysates by using the EnzChek Direct PLC
assay (Invitrogen, Carlsbad, CA, USA). Briefly, 100 μL of
lysates from treated cells were incubated with 100 μL sub-
strate working solution (glycerol-phosphoethanolamine
with a dye-labeled sn-2acyl chain) for 30 minutes and
fluorescence was measured at 490 nm excitation and
520 nm emission on a SpectraMax Gemini EM (Molecular
Devices, Devon, UK). Enzyme activity was normalized to
protein concentration of the respective cell lysate, result-
ing in mU/μg of protein.
Measurement of cellular ATP content
Total ATP content was measured by a luminescence-
based assay using the CellTiter-Glo® Luminescence assay
kit following the manufacturer’s instruction (Promega,
Madison, WI, USA). The assay buffer and substrate were
equilibrated to room temperature. The buffer was trans-
ferred and gently mixed with the substrate to obtain ahomogeneous solution. After cell treatment, 100 μL of
the assay reagent were added into each well and the con-
tent was gently mixed under light protection on an or-
bital shaker to lyse the cells. After 30 minutes, the
luminescence was measured on a Microplate Reader
(SpectraMax GeminiEM, Molecular Devices, Devon, UK).
The luminescence signals for the treated cells were nor-
malized to the luminescence signals from the control
group, which was set as 100%.
Detection of IL-6 by enzyme-linked immunosorbent assay
IL-6 protein secretion in the culture medium of treated
BV-2 cells was quantified using a commercially available
ELISA kit (BD Biosciences, San Jose, CA, USA). Briefly,
96-well plates (Corning Costar 9018, Sigma-Aldrich, St.
Louis, MO, USA) were coated with 50 μL of mouse IL-6
primary antibody in coating buffer and were incubated
overnight at 4°C. After washing with PBS-T (PBS con-
taining 0.05% Tween-20), the wells were blocked with
100 μL of assay diluent and incubated for 1 hour,
washed, and 100 μL of samples or standards were added.
After 2 hours, plates were washed and 50 μL of IL-6 de-
tection antibody diluted 1:250 in assay diluent were
added. Plates were incubated for another 1 hour prior to
another wash step. The enzyme streptavidin alkaline
phosphatase was diluted 1:250 in assay diluent and
50 μL were added per well, followed by incubation for
30 minutes. After washing, 100 μL of substrate solution
was added and incubated for 30 minutes in the dark.
The reaction was stopped with 50 μL of 1 M H3PO4
(stop solution), and absorbance was measured at 450 nm
with a correction of 570 nm using a UV-max kinetic mi-
croplate reader (Molecular Devices, Devon, UK). IL-6
concentrations were calculated from the linear equation
derived from the standard curve of known concentra-
tions of purified mouse IL-6.
Determination of intracellular Ca2+ concentrations
Intracellular Ca2+ levels were measured with the Ca2+-
sensitive dye Fluo-4 AM. Cells were stained with 1 μg/mL
Hoechst-33342 in medium for 30 minutes. Cells were then
washed with HBSS containing 20 mM HEPES and equili-
brated with 1 mL loading solution containing with 5 μM
Fluo-4 AM, 2.5 mM probenecid and 20 mM HEPES in
HBSS for 30 minutes at 37°C, followed by incubation for
30 minutes at room temperature. After loading, cells were
washed twice with HBSS to remove excess fluorescent
dye. Cells were treated for 1 hour with MPEP or thap-
sigargin, followed by the subsequent incubation with thap-
sigargin and MPEP, respectively, for another 1 hour.
Alternatively, BV-2 cells were incubated with MPEP with
or without dantrolene or xestospongin C in HBSS. The
fluorescence intensity of Fluo-4 AM was measured using
an ArrayScan® high-content imaging system (Cellomics
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tured with appropriate filters on 10 fields, with a total
count of approximately 500 cells. Relative changes in Ca2+
concentrations were analyzed as a function of time and
expressed as ΔF/F (in %), with F being the baseline fluor-
escence and ΔF the variation of fluorescence.
Statistical analysis
The data represent mean ± SD and were analyzed using
one-way ANOVA (V5.00; GraphPad Prism Software Inc.,
San Diego, CA, USA), followed by a Tukey’s post hoc test
to determine the specific pairs of groups showing statis-
tically significant differences. A P-value <0.05 was con-
sidered statistically significant.
Results
Inhibition of mGluR5 induces inflammatory mediators
and cellular stress
Microglia are known to increase their production of inflam-
matory mediators as well as ROS and RNS upon activation.Figure 1 Increased cellular stress and inflammatory mediators upon i
24 hours with 100 μM of either CHPG or MPEP. (A) Intracellular reactive ox
(DHE). (B) Mitochondrial mass was measured using MitoTracker®Red CMXR
MitoSOX Red. The expression of inducible nitric oxide synthase (iNOS) mRN
are expressed relative to the values of the house-keeping control GAPDH. (
mean ± SD of three independent experiments. Significance was analyzed b
chloro-5-hydroxyphenylglycine; GAPDH, glyceraldehyde 3-phosphate dehydIn order to investigate the role of mGluR5 on microglial ac-
tivity, we treated BV-2 mouse microglia with the pharmaco-
logical mGluR5 activator CHPG and the inhibitor MPEP
and assessed their impact on cellular stress markers and in-
flammatory mediators. After 24 hours of incubation with
100 μM of the mGluR5 antagonist MPEP, a significant in-
crease (132 ± 5%) of intracellular ROS, detected by DHE,
was observed (Figure 1A). Mitochondrial mass, measured
by MitoTracker®Red CMXRos, was similarly enhanced
(134 ± 6%) (Figure 1B). Mitochondrial superoxide produc-
tion was assessed using MitoSOX Red, which turned out
to be the most sensitive marker for oxidative stress, with
an increase of 314 ± 15% upon treatment with MPEP
(Figure 1C).
In addition, the mRNA expression of iNOS was deter-
mined by quantitative PCR, revealing a three-fold increase
following treatment with MPEP (Figure 1D). Furthermore,
MPEP enhanced the mRNA and protein levels of the in-
flammatory cytokine IL-6 by 6- and 29-fold (Figure 1E,F),
respectively. The agonist CHPG (100 μM) had no effectnhibition of mGluR5 in BV-2 cells. BV-2 cells were treated for
ygen species (ROS) levels were determined using dihydroethidium
os. (C) Mitochondrial superoxide levels were determined using
A (D) and IL-6 mRNA (E) were measured by quantitative PCR. Results
F) IL-6 protein levels were determined by ELISA. Results represent
y one-way ANOVA followed by Tukey’s test. ***P <0.005. CHPG, (RS)-2-
rogenase; MPEP, 2-methyl-6-(phenylethynyl)-pyridine.
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in non-induced BV-2 cells.
Blocking mGluR5 causes ATP depletion and results in
AMPK activation
Enhanced cellular stress is often associated with changes
in ATP levels. Therefore, we measured the intracellular
ATP content in BV-2 cells incubated with 100 μM MPEP.
A time-dependent decrease of total ATP content was ob-
served, reaching significance as early as 1 hour after ex-
posure to MPEP (16 ± 1% lower ATP level) (Figure 2A).
As shown in Figure 2B, treatment of cells for 2 hours with
100 μM MPEP resulted in approximately 40% decreased
cellular ATP levels compared with control cells. Treat-
ment with 1 μM compound C lowered ATP levels. As ex-
pected, pretreatment of the cells with compound C
potentiated the effect of MPEP to reduced ATP levels. In
contrast, 1 mM of the AMPK activator AICAR tended to
increase ATP levels (133 ± 7% compared with control),
and pretreatment of cells with AICAR completely reversed
the ATP depletion observed upon incubation with MPEP
alone.
To further examine the stimulation of AMPK activa-
tion by MPEP, the phosphorylation of the AMPKαFigure 2 ATP depletion and activation of AMP-dependent protein kin
incubated with 100 μM MPEP for 1, 2, 3 and 4 hours, followed by determin
100 μM MPEP, 1 μM of the AMPK inhibitor compound C, 1 mM of the AMP
cellular ATP content. Results represent mean ± SD of three independent expe
test. *P <0.05, ***P <0.005. (C) Immunoblot analyses were performed on lysate
control) for the indicated time period. (D) Densitometric analysis of phospho-
performed on lysates of BV-2 cells that had been pre-incubated with either AI
2 hours. (F) Densitometric analysis of phospho-AMPK band normalized againssubunit was measured by immunoblotting following
treatment with the chemicals indicated for 0.5, 1 and
2 hours (Figure 2C). The signal obtained for phosphory-
lated AMPKα was increased after 1 hour of incubation
with 100 μM MPEP. The positive control (1 mM
AICAR) was slightly more efficient and led to a trend in-
crease of AMPKα phosphorylation already after 0.5 hours
of incubation. AMPK phosphorylation further increased
when the cells were treated with either AICAR or MPEP
for 2 hours, reaching significant difference compared
with control. As shown in Figure 2E,F co-incubation of
BV-2 cells with MPEP and AICAR further enhanced
AMPKα phosphorylation, whereas compound C was
able to reverse the MPEP-induced increase of AMPKα
phosphorylation.
Increased intracellular Ca2+ levels following mGluR5
inhibition
Next, we tested whether the observed ATP depletion
upon inhibition of mGluR5 was associated with an in-
creased [Ca2+]i.
The effects of MPEP on [Ca2+]i were determined using
the fluorescent indicator Fluo-4 AM. BV-2 cells kept in
Ca2+-free medium were incubated with 100 μM MPEPase (AMPK) caused by inhibition of mGluR5. (A) BV-2 cells were
ation of cellular ATP levels. (B) Cells were treated for 2 hours with
K activator AICAR or combinations, followed by determination of
riments. Significance was tested by one-way ANOVA followed by Tukey’s
s of BV-2 cells that had been treated with MPEP or AICAR (positive
AMPK band normalized against β-actin. (E) Immunoblot analyses were
CAR (1 mM) or compound C (1 μM) prior to incubation with MPEP for
t β-actin. MPEP, 2-methyl-6-(phenylethynyl)-pyridine.
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MPEP significantly increased [Ca2+]i (Figure 3A). Subse-
quent addition of the ER Ca2+-ATPase inhibitor thapsigar-
gin resulted in only a small increase in [Ca2+]i, compared
with cells that were treated with thapsigargin alone, sug-
gesting that the observed MPEP-induced rise in [Ca2+]i
was mainly due to Ca2+ release from the ER. As shown in
Figure 3B, [Ca2+]i did no longer respond to MPEP in
cells that were pretreated with thapsigargin, indicating that
ER Ca2+ stores were depleted. To provide initial evidence
for the receptor involved in the Ca2+ efflux from the ER
following exposure to MPEP, we incubated BV-2 cells with
the RyR blocker dantrolene [44] or the IP3R blocker xes-
tospongin C prior to addition of MPEP. While dantrolene
had only a minor inhibiting effect on the increase ofFigure 3 Methyl-6-(phenylethynyl)-pyridine (MPEP) induced Ca2+ rele
to Ca2+-free medium prior to the experiments and loaded with Fluo-4 AM.
addition of 1 μM thapsigargin (▲). Alternatively, as a control, cells were inc
thapsigargin (●). Addition of thapsigargin and MPEP is indicated by an arro
by the addition of 100 μM MPEP (●), or they were kept in Ca2+-free medium f
loaded BV-2 cells were preincubated for 1 hour with 50 μM of the ryanodine
xestospongin C (D) prior to addition of 100 μM MPEP and recording of [Ca2+]
and expressed as ΔF/F (in %), with F being the baseline fluorescence and ΔF
independent experiments.[Ca2+]i by MPEP (Figure 3C), xestospongin C more effect-
ively prevented the MPEP-induced Ca2+ release from the
ER (Figure 3D), suggesting that IP3R is the major target of
mGluR5-mediated signaling.
Induction of ER-stress markers upon inhibition of mGluR5
Disturbances in Ca2+ homeostasis can trigger ER-stress;
therefore we tested whether inhibition of mGluR5 by
MPEP induces ER-stress in BV-2 cells. MPEP treatment
resulted in a time-dependent increase in GRP78 protein
expression (Figure 4A,B). Furthermore, the mRNA expres-
sion levels of the ER-stress markers CHOP, GRP78 and
GRP94 were significantly increased after exposure to
MPEP for 24 hours (3.5-fold, 3.0-fold and 3.8-fold com-
pared with control, respectively) (Figure 4C). To furtherase from the endoplasmic reticulum (ER). BV-2 cells were transferred
(A) Cells were incubated with 100 μM MPEP for 1 hour prior to the
ubated in Ca2+-free medium for 1 hour prior to the addition of 1 μM
w. (B) Cells were treated with 1 μM thapsigargin for 1 hour, followed
or 1 hour, followed by the addition of 100 μM MPEP (▲). Fluo-4 AM
receptor (RyR) blocker dantrolene (C) or 5 μM of the IP3R blocker
i. Relative changes in Ca
2+ concentrations using Fluo-4 AM were analyzed
the variation of fluorescence. Data represent mean ± SD of three
Figure 4 Induction of endoplasmic reticulum (ER)-stress markers by blockage of mGluR5. (A) Immunoblot analyses to detect GRP78
protein were performed on lysates of BV-2 cells that had been treated with 100 μM MPEP for the indicated time period. β-actin served as a
loading control. (B) Densitometric analysis of GRP78 band normalized against β-actin. (C) Cells were preincubated for 1 hour with 1 μM BAPTA-
AM or 1 mM sodium phenylbutyrate (PBA), followed by further incubation with 100 μM MPEP for 24 hours. Expression of CHOP, GRP78 and
GRP94 mRNA were measured by quantitative PCR. (D) Cells were pre-exposed for 1 hour with 1 mM AICAR or 1 μM compound C, followed by a
further incubation with 100 μM MPEP for 2 hours and GRP78 protein levels were analyzed by immunoblotting. (E) Densitometric analysis of
GRP78 band normalized against β-actin. (F) Cells were pre-exposed for 1 hour with 1 mM AICAR or 1 μM compound C, followed by a further
incubation with 100 μM MPEP. Expression of CHOP, GRP78 and GRP94 mRNA were measured by quantitative PCR and mRNA expression levels
were normalized to GAPDH control. Results represent mean ± SD of three independent experiments. Significance was analyzed by one-way
ANOVA followed by Tukey’s tests. **P <0.01; ***P <0.005. CHOP, C/EBP homologous protein; GAPDH, glyceraldehyde 3-phosphate dehydrogenase;
MPEP, 2-methyl-6-(phenylethynyl)-pyridine.
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for 1 hour with 1 mM of the chemical chaperone 4-
phenylbutyrate (4-PBA), followed by incubation with MPEP
for 24 hours. The MPEP-induced increase in the mRNA
expression of the major ER-stress markers was almost fully
prevented by 4-PBA (Figure 4C). To test whether the rise
in [Ca2+]i contributes to the increased expression of the
ER-stress markers, we pretreated BV-2 cells for 1 hour with
1 μM of the Ca2+ chelator BAPTA-AM prior to further in-
cubation in the presence of 100 μM MPEP for 24 hours.
Pretreatment of cells with BAPTA-AM abolished the in-
duction of the expression of the three ER-stress markers,
indicating that the rise in [Ca2+]i is a critical step in the cel-
lular stress response to mGluR5 inhibition.To evaluate whether the effect of MPEP on ER-stress
involves AMPK, we examined the effect of AICAR and
compound C on GRP78 protein expression. Cells were
pretreated with either AICAR (1 mM) or compound C
(1 μM) for 1 hour, followed by incubation with MPEP
(100 μM) for 2 hours. AICAR or compound C treatment
alone did not significantly alter GRP78 protein levels
(data not shown). However, compound C potentiated
the MPEP-mediated induction of GRP78 expression
(Figure 4D,E). In contrast, activation of AMPK activity
by AICAR tended to reduce the MPEP-dependent in-
duction of GRP78 protein expression. Furthermore, we
determined the impact of pretreatment of the cells with
either AICAR (1 mM) or compound C (1 μM) for 1 hour
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levels of CHOP, GRP78 and GRP94 (Figure 4F). Com-
pound C partially prevented the increase in CHOP,
GRP78 and GRP94 mRNA expression levels upon expos-
ure to MPEP, whereas AICAR potentiated the MPEP-
stimulated mRNA expression of the ER-stress markers.
These findings strongly suggest that AMPK is involved in
the MPEP-mediated effects on ER-stress markers in BV-2
cells.Figure 5 Activation of phospholipase C (PLC) upon inhibition of mGlu
measuring the fluorescence intensity of the fluorochrome Fluo-4 AM. BV-2
addition of 100 μM MPEP. Relative changes in the Ca2+ concentrations det
expressed as ΔF/F (in %), with F being the baseline fluorescence and ΔF th
were incubated for 24 hours with 100 μM MPEP in the presence or absenc
determination of mRNA expression of CHOP, GRP78 and GRP95 by quantit
Results represent the mean ± SD from three independent experiments, eac
MPEP for 2 hours with or without pretreatment for 1 hour with 5 μM U-73
total protein) is given as the mean ± SD from three independent experime
or presence of 5 μM PLC inhibitor U-73122 or 1 μM Ca2+ chelator BAPTA-A
immunoblotting. (E) Densitometric analysis of GRP78 band normalized aga
GAPDH, glyceraldehyde 3-phosphate dehydrogenase; MPEP, 2-methyl-6-(phCa2+ release upon inhibition of mGluR5 is dependent on PLC
Activation of PLC produces IP3, which activates IP3R,
thereby inducing Ca2+ release from the ER in a variety of
cells. Therefore, we investigated a possible role of PLC
in the MPEP-dependent Ca2+ release from the ER. As
shown in Figure 5A, MPEP increased [Ca2+]i in a
concentration-dependent manner. Importantly, pretreat-
ment of cells with 5 μM of the PLC inhibitor U-73122
completely abolished the effect of 100 μM MPEP.R5. (A) Intracellular Ca2+ concentrations were determined by
cells were pretreated for 1 hour with 5 μM U-73122 prior to the
ected by Fluo-4 AM were analyzed after 15 minutes. Results are
e variation of fluorescence. Data represent the mean ± SD. (B) Cells
e of 5 μM of the phospholipase C inhibitor U-73122, followed by
ative PCR. Results were normalized to GAPDH mRNA control.
h performed in triplicate. (C), BV-2 cells were incubated with 100 μM
122, followed by determination of PLC activity. PLC activity (mU/μg
nts. (D) BV-2 cells were incubated with 100 μM MPEP in the absence
M, followed by the determination of GRP78 protein expression by
inst β-actin. **P <0.01; ***P <0.001. CHOP, C/EBP homologous protein;
enylethynyl)-pyridine.
Figure 6 Involvement of pertussis toxin-sensitive G-proteins in
the mGluR5-mediated effects. (A) BV-2 cells were pretreated for
6 hours with 100 ng/mL pertussis toxin (PTX) prior to loading with
the fluorochrome Fluo-4 AM and the addition of 100 μM MPEP.
Intracellular Ca2+ concentrations were determined by detecting the
fluorescence intensity of Fluo-4 AM. Relative changes of the Ca2+
concentrations were analyzed after 15 minutes. Results are expressed
as ΔF/F (in %), with F being the baseline fluorescence and ΔF the
variation of fluorescence. (B) BV-2 cells were pretreated for 6 hours
with 100 ng/mL PTX, followed by treatment with 100 μM MPEP for
2 hours. Phospholipase C (PLC) activity was adjusted to total protein
content (mU/μg total protein). Results represent mean ± SD of three
independent experiments and significance was analyzed by one-way
ANOVA followed by Tukey’s test. *P <0.05, ***P <0.005. MPEP,
2-methyl-6-(phenylethynyl)-pyridine.
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GRP78 and GRP96 mRNA expression, measured after
24 hours, was also prevented by cotreatment of the cells
with U-73122 (Figure 5B). Next, we investigated whether
MPEP leads to enhanced PLC activity. Total PLC activity
was significantly increased in cells treated with MPEP
for 2 hours compared with control (Figure 5C). The
MPEP-induced increase in total PLC activity was com-
pletely blocked by pretreatment with U-73122 for 1 hour.
U-73122 also significantly decreased basal PLC activity
in BV-2 cells. In addition, inhibition of PLC by U-73122
reduced the MPEP-induced up-regulation of GRP78 pro-
tein expression (Figure 5D,E). Cotreatment of the cells
with BAPTA-AM also abolished the effect of MPEP, in-
dicating that Ca2+ is directly involved in the MPEP-
dependent induction of ER-stress markers. These results
revealed a role for PLC in the MPEP-induced Ca2+ ele-
vation and ER-stress.
Pertussis toxin-sensitive G-protein coupled receptors are
involved in the mGluR5-mediated effects
Several studies have demonstrated that G-protein coupled
receptors may exert their effects through activation of
PLC, which hydrolyzes phospholipids in cell membranes
to IP3 and diacylglycerol. To investigate the [Ca
2+]i re-
sponses to MPEP, we pretreated cells for 6 hours with
100 ng/mL pertussis toxin (PTX), a specific inhibitor of
Gi/o-type G-proteins. As shown in Figure 6A, pretreat-
ment of cells with PTX completely abolished the MPEP-
induced increase in [Ca2+]i, suggesting the involvement of
Gi/o-proteins in [Ca2+]i responses to MPEP. Pretreatment
of BV-2 cells with PTX prevented the MPEP-dependent
activation of PLC, while PTX alone did not affect basal ac-
tivity of PLC (Figure 6B). These results suggest that MPEP
utilizes a PTX-sensitive G-protein in the activation of
PLC, which leads to enhanced [Ca2+]i and activation of
ER-stress markers. To further investigate the downstream
effects of MPEP after PLC activation and increase in
[Ca2+]i, we investigated whether PTX might suppress the
MPEP-dependent induction of GRP78 expression. Upon
pretreatment of cells for 6 hours with PTX a trend de-
crease in MPEP-induced GRP78 expression was observed
by Western blot analysis; however, the results did not
reach significance (data not shown).
Induction of cellular stress and inflammatory mediators
upon mGluR5 inhibition can be prevented by interfering
with intracellular signaling
In order to further study the impact of the intracellular
signaling pathways that were shown to be influenced by
mGluR5 above, we pretreated BV-2 cells with the various
modulators and measured the effects of MPEP exposure
on the regulation of cellular stress and inflammatory me-
diators. The levels of intracellular ROS, mitochondrial
Figure 7 (See legend on next page.)
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Figure 7 Prevention of cellular stress and inflammatory mediators by interference with intracellular signaling. BV-2 cells were pretreated
for 1 hour with 1 μM compound C, 1 μM BAPTA-AM or 5 μM U-73122, or for 6 hours with pertussis toxin (PTX) (100 ng/mL) prior to incubation
with 100 μM MPEP for 24 hours. (A) Intracellular reactive oxygen species (ROS) levels were determined using dihydroethidium (DHE). (B) Mitochondrial
mass was measured using MitoTracker®Red CMXRos. (C) Mitochondrial superoxide levels were detected using MitoSOX Red. The mRNA expression of
inducible oxygen species (iNOS) (D) and IL-6 (E) were determined by quantitative PCR and values were normalized to GAPDH mRNA control. (F) IL-6
protein expression was measured by ELISA. Results represent the mean ± SD of at least three independent experiments. Significance was tested by
one-way ANOVA followed by Tukey’s test. *P <0.05, **P <0.01; ***P <0.005. GAPDH, glyceraldehyde 3-phosphate dehydrogenase; MPEP,
2-methyl-6-(phenylethynyl)-pyridine.
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as well as IL-6 mRNA and protein were determined. Pre-
treatment of cells with AICAR reversed the effects of
MPEP on cellular stress parameters and cytokine expres-
sion, whereas compound C potentiated them (Figure 7).
BAPTA-AM, U-73122 and PTX completely abolished
the MPEP-dependent induction of ROS production and
inflammatory cytokine expression. Together, these data
suggest that blockage of mGluR5 by MPEP leads to the ac-
tivation of PTX-sensitive G-proteins that causes activation
of PLC, with subsequent Ca2+ release from the ER,
thereby producing cellular stress and enhancing the ex-
pression of inflammatory cytokines.
Discussion
Several reports have shown that mGluR5 exerts neuropro-
tective effects in microglia cells by modulating oxidative
stress and inflammatory cytokine release both in vitro and
in vivo. It has been shown that the mGluR5 agonist CHPG
diminished NF-κB activation, NADPH oxidase activity
and ROS production in lipopolysaccharide (LPS)-stimu-
lated microglia and improved functional recovery after
traumatic brain injury [7,8,12]. Delayed CHPG administra-
tion suppressed the activation of microglia and chronic
neuroinflammation and decreased the hippocampal neur-
onal loss and lesion progression following experimental
traumatic brain injury in mice [9]. Byrnes et al. showed
that in primary microglia from mGluR5-deficient mice
CHPG was no longer able to decrease the LPS-induced in-
flammation and oxidative stress, indicating a key role for
mGluR5 in the modulation of microglial activation [10].
Furthermore, they provided evidence for a role of PLC,
PKC and Ca2+ in the mGluR5-mediated effects. In con-
trast to its activation, the possible consequences of the in-
hibition of mGluR5 by xenobiotics on cellular stress
parameters and inflammatory mediators in microglia re-
mains less well understood.
In the present study, we used BV-2 mouse microglia
cells, which show highly overlapping gene expression
profiles with primary mouse microglia and therefore
represent a valuable model system for primary mouse
microglia [41], to investigate the effects of the mGluR5
blocker MPEP on cellular stress parameters, inflamma-
tory mediators and the underlying signaling pathways.Although MPEP is widely used to modulate the mGluR5
receptor it has been reported that the compound lacks
sensitivity against mGluR5, leading to off-target effects
while antagonizing other receptors. Thus, it has been
shown that MPEP exerts neuroprotective effects at high
concentrations, mediated by inhibition of the N-methyl-
D-aspartate receptor (NMDA) [45]. MPEP, at the concentra-
tions used in the present study, may have off-target effects
in vivo. Specifically, MPEP has been shown to antagonize
the mGluR1 and NR2B receptors [46] and positively
regulate the mGluR4 receptor [47]. BV-2 cells express
high protein levels of mGluR5 and very low levels of
mGluR1 [13]. Additionally, evidence shows that the effect
of MPEP on the NR2B and mGluR4 receptor would be
neuroprotective [47,48]. Since our results show that MPEP
induces cellular stress, we are confident that MPEP is tar-
geting mGluR5; however, contribution of other affected
targets to the observed results cannot be excluded. More
selective antagonists of mGluR5 receptors such as the re-
cently developed 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl]
pyridine (MTEP) might be used to address possible off-
target effects. Exposure of BV-2 cells to MPEP increased
total and mitochondrial ROS production, caused mito-
chondrial swelling and enhanced the expression of iNOS
as well as the expression and release of IL-6 (Figure 8).
CHPG completely reversed the effects of MPEP, indicating
that the MPEP-induced oxidative stress and up-regulation
of cytokines was mediated by mGluR5 inactivation (data
not shown). These results are consistent with previous
studies reporting a protective role of microglial mGluR5
activation on neuronal cells and in preventing brain dam-
age [9-12,49].
On the other side, some studies provided evidence for
neuroprotective effects of mGluR5 inhibition by MPEP.
A prolonged exposure of spinal cord motor neurons to
cultures enriched in reactive astrocytes to MPEP re-
duced AMPA-mediated toxicity and cobalt uptake in
motor neurons [50]. The protective effect of MPEP was
absent in cultures with low astrocyte numbers, suggest-
ing that blockade of mGluR5 in astrocytes was respon-
sible for the observed effects. Thus, mGluR5 likely
exerts differential effects in microglia and astrocytes.
Another study showed a neuroprotective effect of MPEP
in a rodent 6-hydroxydopamine Parkinson’s disease
Figure 8 Schematic presentation of signaling mechanisms and cellular outcomes following mGluR5 blockade.
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minergic activity to the substantia nigra pars compacta
may contribute to the progression of nigral dopamin-
ergic neuronal degeneration and that mGluR5 blockers
might delay disease progression. The exact mode of ac-
tion, however, remained unclear.
To begin to understand why mGluR5 blockade results
in enhanced cellular stress in microglia, we investigated
the mGluR5-mediated signaling pathway in BV-2 cells
upon treatment with MPEP. Our results revealed a rapid
increase in [Ca2+]i, with peak concentrations reached
15 minutes after addition of MPEP and return to baseline
after 40 minutes. The fact that pre-exposure of cells to
thapsigargin completely abolished the MPEP-induced in-
crease in [Ca2+]i, and vice versa pre-incubation with MPEP
reduced thapsigargin-induced [Ca2+]i increase, indi-
cated that Ca2+ was released from the ER. Furthermore,
the IP3R blocker xestospongin C effectively prevented
the MPEP-induced Ca2+ release from the ER, whereas
the RyR antagonist dantrolene was less effective, sug-
gesting a major role for IP3R in the mGluR5-dependent
signaling pathway.
Changes in [Ca2+]i represent a major signaling path-
way in microglia. Exposure of microglia to LPS leads to
chronically elevated [Ca2+]i and it was shown that the
Ca2+ chelator BAPTA-AM could prevent the LPS-
induced release of NO and the cytokines TNF-α, IL-6
and IL-12 [52]. Importantly, blockade of IP3R by xestos-
pongin C has been shown to abolish the production of
TNF-α and IL-6 in activated microglia [53].
Impaired microglial Ca2+-mediated signal transduction
was observed under pathological conditions. Exposure to
amyloid-β increased [Ca2+]i in cultured microglia, and
basal [Ca2+]i was higher in microglia isolated from the
brain of Alzheimer’s patients compared with microglia
from non-demented individuals [54,55]. Increased [Ca2+]i
may act directly on the mitochondrial membrane, leading
to enhanced ROS production [56,57]. Furthermore, a Ca2+
overload decreases mitochondrial function by triggering
the opening of the mitochondrial membrane permeability
transition pore, resulting in mitochondrial membrane
depolarization and swelling, enhanced ROS generation
and decreased ATP production [58-60].Mitochondrial dysfunction and ATP depletion have
been associated with increased oxidative stress and neu-
roinflammation [61-63]. The rapid ATP depletion ob-
served in the present study in BV-2 cells following
incubation with MPEP could be caused by excessive
ATP consumption by ER Ca2+-ATPases attempting to
lower [Ca2+]i by Ca
2+ reuptake into the ER and/or mito-
chondrial dysfunction and impaired ATP production.
The MPEP-dependent ATP depletion was ameliorated
by pretreatment of cells with the AMPK inducer AICAR,
indicating an involvement of AMPK in the modulation
of the mGluR5-mediated effects. The depletion of ATP
is likely to occur prior to the induction of AMPKα phos-
phorylation, in line with the role of AMPK in restoring
cellular ATP levels [64]. Studies in BV-2 microglia and
in glial cells have shown that the pharmacological acti-
vation of AMPK suppresses the pro-inflammatory re-
sponses [65,66]. On the other side, AMPK activation
was found to enhance ROS production in microglia and
in pancreatic beta-cells exposed to high glucose levels
[67-69], and some of the observations may depend on
the specific conditions of the respective study. Neverthe-
less, the results of the present study provide, to our
knowledge, the first evidence for an association between
mGluR5 inhibition and subsequent ATP depletion and
AMPK activation in microglia.
The excessive Ca2+ release from the ER may be re-
sponsible for the observed ATP depletion. It may further
lead to the depletion of ER luminal Ca2+ stores, which is
believed to trigger ER-stress and activate the UPR path-
way, including the induction of the expression of ER
chaperones such as CHOP, GRP78 and GRP96 [35]. In
this study, we observed that the MPEP-induced expres-
sion of CHOP, GRP78 and GRP96 was attenuated by the
Ca2+ chelator BAPTA-AM in BV-2 cells, suggesting that
the ER-stress, caused upon mGluR5 inhibition, was
dependent on increased [Ca2+]i.
Impaired AMPK signaling has been associated with
ER-stress in different cell types [36,38,70]. We found
that the MPEP-mediated induction of ER-stress markers
was potentiated by the AMPK inhibitor compound C
and diminished by the activator AICAR. Importantly,
pretreatment of BV-2 cells with either compound C or
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[Ca2+]i (data not shown), suggesting that the Ca
2+ re-
lease from the ER precedes ATP depletion and AMPK
activation. The protective effects of pretreatment of cells
with AICAR may be explained by an increased cytoplas-
mic ATP concentration, which may facilitate energy
dependent transport of Ca2+ back into the ER following
mGluR5 blockade.
The MPEP-dependent increase in [Ca2+]i and subse-
quent induction of ER-stress markers and mitochondrial
dysfunction involved the activation of PLC and could be
prevented by pretreatment of BV-2 cells with the PLC in-
hibitor U-73122. Importantly, an increased PLC activity
could be measured following incubation of microglia with
MPEP, suggesting that mGluR5 inhibition caused cellular
stress via the excessive activation of the PLC-IP3 pathway.
It was reported that the mGluR5 agonist CHPG reduced
the LPS-dependent inflammatory response and activated
PLC, thereby increasing [Ca2+]i in microglia [10]. Thus, a
tight control of the balance of mGluR5 signaling is import-
ant to avoid cellular stress. Additionally, mGluR5 might
cross regulate toll-like receptors, thereby resulting in a
muted inflammatory response.
Classically, the activation of PLC resulting in the synthe-
sis of IP3 and the release of Ca
2+ from the ER was associ-
ated with Gq-coupled receptors [39]. In the present study,
the MPEP-induced increase in [Ca2+]i was attenuated by
the Gi-protein inhibitor PTX, the PLC inhibitor U-73122
and the IP3R antagonist xestospongin C, thus suggesting
crosstalk between mGluR5 receptors and Gi-protein sub-
units to modulate PLC and induce IP3R-mediated Ca
2+ re-
lease from the ER. Several studies in a variety of cells and
tissues demonstrated an increase in [Ca2+]i following
stimulation of Gi-coupled receptors [39,71,72]. For in-
stance, treatment of natural killer cells with PTX dimin-
ished intracellular Ca2+ influx and chemotaxis induced by
oxidized lipids and lysophosphatidylcholine [72]. Further,
PTX completely blocked the Ca2+ responses induced by
the endogenous μ-opioid receptor agonist endomorphin-1
in astrocytes [73].
Conclusions
The present study demonstrates for the first time that
antagonism of mGluR5 in BV-2 microglia results in
increased cellular stress with mitochondrial dysfunction
and ER-stress caused by an activation of PTX-sensitive
Gi-proteins and subsequent PLC activation and IP3-
dependent Ca2+ release from the ER. The increase in [Ca2+]i
upon inhibition of mGluR5 was followed by a depletion
of cellular ATP and activation of AMPK, resulting in
the induction of pro-inflammatory mediators. The re-
sults suggest that xenobiotics inhibiting mGluR5 dis-
rupt Ca2+ signaling and redox regulation in microglia,
thereby promoting neuroinflammation.Additional file
Additional file 1: Table S1. Oligonucleotide primers for real-time PCR.
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